HB 1301 — An Act requiring health insurance policies to provide coverage for pre-exposure prophylaxis and post-exposure prophylaxis HIV medication and associated laboratory tests and patient visits.
Congress · introduced 2025-04-28
Latest action: — Referred to HEALTH, April 28, 2025
Sponsors
- Tarik Khan (D, PA-194) — sponsor · 2025-04-28
- Malcolm Kenyatta (D, PA-181) — cosponsor · 2025-04-28
- Bridget M. Kosierowski (D, PA-114) — cosponsor · 2025-04-28
- Rick Krajewski (D, PA-188) — cosponsor · 2025-04-28
- Greg Scott (D, PA-54) — cosponsor · 2025-04-28
- Jose Giral (D, PA-180) — cosponsor · 2025-04-28
- Benjamin V. Sanchez (D, PA-153) — cosponsor · 2025-04-28
- Nancy Guenst (D, PA-152) — cosponsor · 2025-04-28
- Liz Hanbidge (D, PA-61) — cosponsor · 2025-04-28
- Chris Pielli (D, PA-156) — cosponsor · 2025-04-28
- Steven R. Malagari (D, PA-53) — cosponsor · 2025-04-28
- La'Tasha D. Mayes (D, PA-24) — cosponsor · 2025-04-28
- Joseph C. Hohenstein (D, PA-177) — cosponsor · 2025-04-28
- Johanny Cepeda-Freytiz (D, PA-129) — cosponsor · 2025-04-28
- Mandy Steele (D, PA-33) — cosponsor · 2025-04-28
- Carol Hill-Evans (D, PA-95) — cosponsor · 2025-04-28
- Danielle Friel Otten (D, PA-155) — cosponsor · 2025-04-28
- G. Roni Green (D, PA-190) — cosponsor · 2025-04-28
- Mary Jo Daley (D, PA-148) — cosponsor · 2025-04-28
- Lisa A. Borowski (D, PA-168) — cosponsor · 2025-04-28
- Andre D. Carroll (D, PA-201) — cosponsor · 2025-04-28
Action timeline
- · house — Referred to HEALTH, April 28, 2025
Text versions
No text versions on file yet — same ingest as the action timeline populates these. Each version has direct links to the XML / HTML / PDF at govinfo.gov.
Bill text
Printer's No. 1495 · 6,188 characters · source document
Read the full text
PRINTER'S NO. 1495
THE GENERAL ASSEMBLY OF PENNSYLVANIA
HOUSE BILL
No. 1301
Session of
2025
INTRODUCED BY KHAN, KENYATTA, KOSIEROWSKI, KRAJEWSKI, SCOTT,
GIRAL, SANCHEZ, GUENST, HANBIDGE, PIELLI, MALAGARI, MAYES,
HOHENSTEIN, CEPEDA-FREYTIZ, STEELE, HILL-EVANS, OTTEN, GREEN,
DALEY, BOROWSKI AND CARROLL, APRIL 28, 2025
REFERRED TO COMMITTEE ON HEALTH, APRIL 28, 2025
AN ACT
1 Requiring health insurance policies to provide coverage for pre-
2 exposure prophylaxis and post-exposure prophylaxis HIV
3 medication and associated laboratory tests and patient
4 visits.
5 The General Assembly of the Commonwealth of Pennsylvania
6 hereby enacts as follows:
7 Section 1. Short title.
8 This act shall be known and may be cited as the PrEP and PEP
9 for Pennsylvania Act.
10 Section 2. Definitions.
11 The following words and phrases when used in this act shall
12 have the meanings given to them in this section unless the
13 context clearly indicates otherwise:
14 "Health care provider." A licensed hospital or health care
15 facility or a person licensed, certified or otherwise regulated
16 to provide health care services under the laws of this
17 Commonwealth, including a physician, psychologist, emergency
18 medical services worker, advanced practice registered nurse or
1 physician's assistant.
2 "Health insurance policy." As follows:
3 (1) An individual or group health insurance policy,
4 contract or plan that provides medical or health care
5 coverage by a health care provider on an expense-incurred
6 service or prepaid basis that is offered by or is governed
7 under any of the following:
8 (i) The act of May 17, 1921 (P.L.682, No.284), known
9 as The Insurance Company Law of 1921, including section
10 630 of that act.
11 (ii) The act of December 29, 1972 (P.L.1701,
12 No.364), known as the Health Maintenance Organization
13 Act.
14 (iii) 40 Pa.C.S. Ch. 61 (relating to hospital plan
15 corporations) or 63 (relating to professional health
16 services plan corporations).
17 (2) The term does not include accident only, fixed
18 indemnity, hospital indemnity, limited benefit, credit,
19 dental, vision, specified disease, Medicare supplement, long-
20 term care, disability income, workers' compensation,
21 automobile medical payment insurance or a policy under which
22 benefits are provided by the Federal Government to active or
23 former military personnel and their dependents.
24 "HIV." The human immunodeficiency virus.
25 "PEP." A post-exposure prophylaxis HIV medication that is
26 approved by the United States Food and Drug Administration and
27 that can be taken as a prophylaxis to prevent the transmission
28 of the human immunodeficiency virus after a person is exposed.
29 "PrEP." A pre-exposure prophylaxis HIV medication that is
30 approved by the United States Food and Drug Administration and
20250HB1301PN1495 - 2 -
1 that can be taken as a prophylaxis to prevent the transmission
2 of the human immunodeficiency virus before a person is exposed.
3 "Prescriber." A person licensed, registered or otherwise
4 lawfully authorized to distribute, dispense or administer
5 medication.
6 Section 3. Mandated coverage.
7 (a) Requirements.--
8 (1) A health insurance policy that is offered, issued or
9 renewed in this Commonwealth on or after the effective date
10 of this subsection shall provide coverage for all the
11 expenses associated with PEP and PrEP, including the costs of
12 associated laboratory tests, patient visits to a health care
13 provider for the purpose of HIV medication counseling and
14 patient visits to a prescriber to have PEP and PrEP
15 prescribed or maintained.
16 (2) A patient shall not incur any copay, coinsurance,
17 deductible or other costsharing for any of the expenses
18 associated with PEP and PrEP, including the costs of
19 associated laboratory tests, patient visits to a health care
20 provider for the purpose of HIV medication counseling and
21 patient visits to a prescriber to have PEP or PrEP prescribed
22 or maintained.
23 (b) Specialty tier.--A provider of a health insurance policy
24 may not move a PEP or PrEP, or an associated laboratory service
25 for monitoring, visit to a health care provider or visit to a
26 prescriber, into a specialty tier solely for monetary gain.
27 (c) Counseling.--Unless medically necessary, a health
28 insurance policy shall not require counseling by an infectious
29 disease specialist or immunologist as a condition to receive PEP
30 or PrEP, or an associated laboratory service for monitoring,
20250HB1301PN1495 - 3 -
1 visit to a health care provider or visit to a prescriber.
2 Section 4. Applicability.
3 This act shall apply as follows:
4 (1) For health insurance policies for which either rates
5 or forms are required to be filed with the Federal Government
6 or the Insurance Department, this act shall apply to any
7 policy for which a form or rate is first filed on or after
8 the effective date of this paragraph.
9 (2) For health insurance policies for which neither
10 rates nor forms are required to be filed with the Federal
11 Government or the Insurance Department, this act shall apply
12 to any policy issued or renewed on or after 180 days after
13 the effective date of this paragraph.
14 Section 5. Effective date.
15 This act shall take effect in 60 days.
20250HB1301PN1495 - 4 -Connected on the graph
Outbound (1)
| date | type | to | amount | role | source |
|---|---|---|---|---|---|
| — | referred_to_committee | Pennsylvania House Health Committee | — | pa-leg |
The full graph
Every typed relationship touching this entity — 1 edge across 1 category. Grouped by what the connection is; the heaviest few are shown, with a link to the full list.
Committees
→ Referred to committee 1 edge
Who matters
Members ranked by combined influence on this bill: role (sponsor 5 / cosponsor 1), capped speech count from the Congressional Record, and recorded-vote engagement.
| # | Member | Role | Speeches | Voted | Score |
|---|---|---|---|---|---|
| 1 | Tarik Khan (D, state_lower PA-194) | sponsor | 0 | — | 5 |
| 2 | Andre D. Carroll (D, state_lower PA-201) | cosponsor | 0 | — | 1 |
| 3 | Benjamin V. Sanchez (D, state_lower PA-153) | cosponsor | 0 | — | 1 |
| 4 | Bridget M. Kosierowski (D, state_lower PA-114) | cosponsor | 0 | — | 1 |
| 5 | Carol Hill-Evans (D, state_lower PA-95) | cosponsor | 0 | — | 1 |
| 6 | Chris Pielli (D, state_lower PA-156) | cosponsor | 0 | — | 1 |
| 7 | Danielle Friel Otten (D, state_lower PA-155) | cosponsor | 0 | — | 1 |
| 8 | G. Roni Green (D, state_lower PA-190) | cosponsor | 0 | — | 1 |
| 9 | Greg Scott (D, state_lower PA-54) | cosponsor | 0 | — | 1 |
| 10 | Johanny Cepeda-Freytiz (D, state_lower PA-129) | cosponsor | 0 | — | 1 |
| 11 | Jose Giral (D, state_lower PA-180) | cosponsor | 0 | — | 1 |
| 12 | Joseph C. Hohenstein (D, state_lower PA-177) | cosponsor | 0 | — | 1 |
| 13 | La'Tasha D. Mayes (D, state_lower PA-24) | cosponsor | 0 | — | 1 |
| 14 | Lisa A. Borowski (D, state_lower PA-168) | cosponsor | 0 | — | 1 |
| 15 | Liz Hanbidge (D, state_lower PA-61) | cosponsor | 0 | — | 1 |
| 16 | Malcolm Kenyatta (D, state_lower PA-181) | cosponsor | 0 | — | 1 |
| 17 | Mandy Steele (D, state_lower PA-33) | cosponsor | 0 | — | 1 |
| 18 | Mary Jo Daley (D, state_lower PA-148) | cosponsor | 0 | — | 1 |
| 19 | Nancy Guenst (D, state_lower PA-152) | cosponsor | 0 | — | 1 |
| 20 | Rick Krajewski (D, state_lower PA-188) | cosponsor | 0 | — | 1 |
| 21 | Steven R. Malagari (D, state_lower PA-53) | cosponsor | 0 | — | 1 |
Predicted vote
Aggregated from: actual roll-call votes (when present) → sponsor → cosponsor → party median (predicts YES when ≥25% of the caucus sponsored/cosponsored). Each row labels its confidence tier so you can see why a position was predicted.
0 predicted yes (0%) · 543 predicted no (100%) · 0 unknown (0%)
By party: · R: 0 yes / 277 no · D: 0 yes / 263 no · I: 0 yes / 3 no
Activity
Every typed-graph event involving this entity, newest first. Each row is one edge in the influence graph; click the date to jump to its provenance.
- 2026-05-20 · was referred to Pennsylvania House Health Committee · pa-leg